课题基金 / 基金详情

CONTROL MECHANISMS IN HUMAN TUMOR CELLS--SMALL RNAS

CONTROL MECHANISMS IN HUMAN TUMOR CELLS--SMALL RNAS
人类肿瘤细胞的控制机制——小RNAS
批准号:
3165355
负责人:
George L Eliceiri
金额:
$11.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1977
资助国家:
美国
项目状态:
已结题
起止时间:
1977-08-01 至 1986-07-31

项目摘要

项目成果

George L Eliceiri的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We are studying some effects of the major environmental carcinogen, ultraviolet (UV) radiation, on human and other eukaryotic cells. Three unprecedented observations were made in this laboratory about the effect of UV radiation on the accumulation of newly synthesized small nuclear RNA (snRNA) species U1, U2, U3, U4, and U5: (1) although U snRNAs are small (for example, human U1 RNA is 165 nucleotides long), their biosynthesis is very sensitive to UV radiation; (2) the inactivation curve of their synthesis is monophasic, instead of the usual single slope; and (3) the inhibition of U1-U5 snRNA synthesis increases within the first two hours after UV irradiation (although inhibited transcription usually returns to normal as pyrimidine dimers are removed from DNA). We now wish to investigate the mechanisms behind these puzzling observations. This includes determining the step within the U snRNA biosynthesis pathway which is affected by UV radiation, e.g., initiation, elongation, or termination of transcription?). Another goal is to find out what the critical alteration involved in this inhibition is; e.g., formation of pyrimidine dimers, hypersensitivity to postirradiation repair nicks in DNA, or ensuing changes in DNA torsional stress. An additional objective is to define the portion of genomic DNA required to obtain the inhibitory effects of UV radiation on U1-U5 snRNA synthesis. The approaches to be used are: radiolabeling experiments with whole cells including hybrid selection assays; transcription in isolated nuclei and in a soluble in vitro system; transcription in thymidine kinase-deficient cells that have been transfected with cloned U1 genes. (H)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ribosome Biogenesis: Small Nucleolar RNPs
  • 批准号:
    7046830
  • 项目类别:
  • 资助金额:
    $22.09万
  • 财政年份:
    2002
  • 负责人:
    George L Eliceiri
  • 依托单位:
Ribosome Biogenesis: Small Nucleolar RNPs
  • 批准号:
    6620460
  • 项目类别:
  • 资助金额:
    $22.64万
  • 财政年份:
    2002
  • 负责人:
    George L Eliceiri
  • 依托单位:
Ribosome Biogenesis: Small Nucleolar RNPs
  • 批准号:
    6721214
  • 项目类别:
  • 资助金额:
    $22.63万
  • 财政年份:
    2002
  • 负责人:
    George L Eliceiri
  • 依托单位:
Ribosome Biogenesis: Small Nucleolar RNPs
  • 批准号:
    6417797
  • 项目类别:
  • 资助金额:
    $22.69万
  • 财政年份:
    2002
  • 负责人:
    George L Eliceiri
  • 依托单位:
国内基金
海外基金
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    程子译
  • 依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
  • 批准号:
    2026JJ81091
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘亮
  • 依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
  • 批准号:
    2026JJ50010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    应站明
  • 依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
  • 批准号:
    JCZRLH202600588
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: